LUZ11

Luzitin SA · Phase 1 active Small molecule

At a glance

Generic name	LUZ11
Sponsor	Luzitin SA
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Photodynamic Therapy With LUZ11 in Advanced Head and Neck Cancer (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

LUZ11 CI brief — competitive landscape report
LUZ11 updates RSS · CI watch RSS
Luzitin SA portfolio CI